News
Affluent Medical meets a major milestone with the first clinical trial of ARTUS
• Positive results from the first clinical study on 3 patients implanted between May and September 2018 • The implant technique, via laparoscopy and open surgery, was validated, surgical safety was also verified • Implantable in about 20 minutes...
Affluent Medical announces the successful conclusion of its OPTIMISE clinical study for KALIOS
Affluent Medical announces today the positive conclusion of its OPTIMISE first clinical study for KALIOS, its adjustable mitral repair device. KALIOS has been implanted in five patients between January and May of the current year by Prof. Martin...
Key opinion Leader event
AFFLUENT MEDICAL hosted a Key Opinion Leader event Wednesday, May 23, 2018 on New Generation Technologies for Minimally Invasive Surgery of the Mitral Valve and Abdominal Aorta.Key opinion leaders (KOLs) present were Professor Christian...
Preclinical study
AFFLUENT MEDICAL announces that it has received the approval from the Czech Republic regulatory authority to start ‘first in man’ preclinical study with ARTUS. ARTUS is the first electronically activated sphincter to treat urinary incontinence. One...
The first adjustable Kalios ring
AFFLUENT MEDICAL announces that it has successfully implanted at the Vienna General Hospital, Austria, the first adjustable Kalios ring, intended to restore the normal functioning of the mitral valve with closing defects in some patients. KALIOS is...
